Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human fibrinogen in congenital fibrinogen deficiency
CTR20231107Phase 3Completed
- Sponsor
- Tonglu Biopharmaceutical
- Start
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Fibrinogen human in fibrinogen deficiency, congenital afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia, sponsored by Tonglu Biopharmaceutical. Started Jul 2023; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
fibrinogen deficiencycongenital afibrinogenemiahypofibrinogenemiadysfibrinogenemia
Beyond the preview
Go deeper on CTR20231107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231107.